KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 162 filers reported holding KARUNA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 3.11 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,502,703 | -40.9% | 8,887 | -24.2% | 0.00% | -50.0% |
Q2 2023 | $2,542,784 | +28.3% | 11,726 | +7.4% | 0.00% | +100.0% |
Q1 2023 | $1,982,601 | -7.5% | 10,915 | +0.0% | 0.00% | -50.0% |
Q4 2022 | $2,144,209 | +21.8% | 10,912 | +39.5% | 0.00% | +100.0% |
Q3 2022 | $1,760,000 | +85.9% | 7,823 | +4.5% | 0.00% | 0.0% |
Q2 2022 | $947,000 | +0.1% | 7,483 | +0.3% | 0.00% | 0.0% |
Q1 2022 | $946,000 | -1.0% | 7,462 | +2.3% | 0.00% | 0.0% |
Q4 2021 | $956,000 | -23.2% | 7,293 | -28.3% | 0.00% | 0.0% |
Q3 2021 | $1,245,000 | +11.6% | 10,176 | +4.0% | 0.00% | 0.0% |
Q2 2021 | $1,116,000 | 0.0% | 9,786 | +5.4% | 0.00% | 0.0% |
Q1 2021 | $1,116,000 | +15.6% | 9,283 | -2.3% | 0.00% | 0.0% |
Q4 2020 | $965,000 | +132.0% | 9,499 | +76.5% | 0.00% | – |
Q3 2020 | $416,000 | -54.5% | 5,381 | -34.4% | 0.00% | -100.0% |
Q2 2020 | $914,000 | – | 8,204 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sofinnova Investments, Inc. | 1,952,441 | $150,963,000 | 11.19% |
Eventide Asset Management | 901,077 | $69,671,000 | 1.36% |
First Light Asset Management, LLC | 128,200 | $9,912,000 | 1.02% |
Prosight Management, LP | 15,826 | $1,224,000 | 0.58% |
MOODY ALDRICH PARTNERS LLC | 30,970 | $2,395,000 | 0.50% |
PFM Health Sciences, LP | 137,960 | $10,667,000 | 0.49% |
Rock Springs Capital Management LP | 244,106 | $18,874,000 | 0.48% |
Atika Capital Management LLC | 73,500 | $5,683,000 | 0.46% |
Hood River Capital Management LLC | 132,400 | $10,237,000 | 0.44% |
CATALYST PRIVATE WEALTH, LLC | 5,006 | $387,000 | 0.38% |